Is there a sex difference in adult salivary clearance of caffeine (1,3,7-trimethylpurine-2,6-dione)?

[1]  T. Murayama,et al.  Assays for Modulators of Ryanodine Receptor (RyR)/Ca2+ Release Channel Activity for Drug Discovery for Skeletal Muscle and Heart Diseases , 2019, Current protocols in pharmacology.

[2]  Randle Aaron M. Villanueva,et al.  ggplot2: Elegant Graphics for Data Analysis (2nd ed.) , 2019, Measurement: Interdisciplinary Research and Perspectives.

[3]  A. Böttger,et al.  Lessons on Caffeine, Cannabis & Co: Plant-derived Drugs and their Interaction with Human Receptors , 2018, Learning Materials in Biosciences.

[4]  A. Raggi,et al.  Is Medication Overuse Drug Specific or Not? Data from a Review of Published Literature and from an Original Study on Italian MOH Patients , 2018, Current Pain and Headache Reports.

[5]  L. Valentín-Blasini,et al.  Caffeine Concentrations in Coffee, Tea, Chocolate, and Energy Drink Flavored E-liquids , 2016, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

[6]  R. Brand,et al.  Using Caffeine Pills for Performance Enhancement. An Experimental Study on University Students’ Willingness and Their Intention to Try Neuroenhancements , 2016, Front. Psychol..

[7]  L. Spriet.  Exercise and Sport Performance with Low Doses of Caffeine , 2014, Sports Medicine.

[8]  J. Mustard.  The buzz on caffeine in invertebrates: effects on behavior and molecular mechanisms , 2014, Cellular and Molecular Life Sciences.

[9]  U. Fuhr,et al.  Assessment of CYP1A2 activity in clinical practice: why, how, and when? , 2005, Basic & clinical pharmacology & toxicology.

[10]  Uwe Fuhr,et al.  Induction of Drug Metabolising Enzymes , 2000, Clinical pharmacokinetics.

[11]  U. Fuhr,et al.  Estimation of cytochrome P-450 CYP1A2 activity in 863 healthy Caucasians using a saliva-based caffeine test. , 1999, Pharmacogenetics.

[12]  G. Kearns,et al.  Quantitation of three‐month intraindividual variability and influence of sex and menstrual cycle phase on CYP1A2, N‐acetyltransferase‐2, and xanthine oxidase activity determined with caffeine phenotyping , 1998, Clinical pharmacology and therapeutics.

[13]  R. Tukey,et al.  Caffeine metabolism by human hepatic cytochromes P450: contributions of 1A2, 2E1 and 3A isoforms. , 1994, Biochemical pharmacology.

[14]  R. E. Small,et al.  Liver Function Assessment by Drug Metabolism , 1990, Pharmacotherapy.

[15]  J. Casida,et al.  Ca2+-activated ryanodine binding: mechanisms of sensitivity and intensity modulation by Mg2+, caffeine, and adenine nucleotides. , 1987, Molecular pharmacology.

[16]  V. Khanna,et al.  The role of salivary caffeine clearance in the diagnosis of chronic liver disease. , 2015, Journal of oral biology and craniofacial research.

[17]  R Core Team,et al.  R: A language and environment for statistical computing. , 2014 .

[18]  T. Hartman,et al.  Beverage caffeine intakes in the U.S. , 2014, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[19]  R. de Caterina,et al.  Genetic determinants of blood pressure responses to caffeine drinking. , 2012, The American journal of clinical nutrition.

[20]  M. Arnaud.  Pharmacokinetics and metabolism of natural methylxanthines in animal and man. , 2011, Handbook of experimental pharmacology.

[21]  M. Lind,et al.  Plasma and salivary pharmacokinetics of caffeine in man , 2004, European Journal of Clinical Pharmacology.

[22]  K. E. Newhouse.  Goodman and Gilman's The Pharmacological Basis of Therapeutics , 1986, The Yale Journal of Biology and Medicine.